The effect of nicotinamide on microregional blood flow within tumours assessed using laser Doppler probes.

Laser Doppler probes have been used to provide real-time spatial flow mapping of microregional erythrocyte flux within the murine Sarcoma F (SaF). The results demonstrate that fluctuations in microregional red blood cell flux are a common feature of SaF tumours, with approximately 50% of regions demonstrating a change of at least a factor of 2 over a one-hour sampling period and 16% of regions showing a greater than 5-fold change. Administration of 250 mg/kg nicotinamide induced a small reduction in the number of microregions showing fluctuations, 9% of regions demonstrated large fluctuations (i.e., > or = 5) relative to 16% in control tumours. At a dose of 500 mg/kg, the number of changes in microregional erythrocyte flux was increased. However, unlike either untreated or nicotinamide 250 mg/kg pretreated animals, these changes were mostly increases in microregional flow. Indeed, 12 of the 13 changes by a factor of 5 or greater, observed following nicotinamide at 500 mg/kg, were increases. This effect on microregional flow translated into only a 25% increase in macroregional flow determined by averaging all the regions sampled.

[1]  P Vaupel,et al.  Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  M. Trotter,et al.  Modification of tumour radiation response in vivo by the benzamide analogue pyrazinamide. , 1990, British Journal of Cancer.

[3]  L. H. Gray,et al.  The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy , 1955, British Journal of Cancer.

[4]  R. Bush The significance of anemia in clinical radiation therapy. , 1986, International journal of radiation oncology, biology, physics.

[5]  J. Overgaard Sensitization of hypoxic tumour cells--clinical experience. , 1989, International journal of radiation biology.

[6]  J. Overgaard,et al.  Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing. , 1994, Acta oncologica.

[7]  M. Trotter,et al.  Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumor. , 1990, Journal of the National Cancer Institute.

[8]  S. Rockwell,et al.  Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. , 1984, International journal of radiation oncology, biology, physics.

[9]  M. Trotter,et al.  The use of fluorescent probes to identify regions of transient perfusion in murine tumors. , 1989, International journal of radiation oncology, biology, physics.

[10]  H. Hewitt,et al.  SURVIVAL CURVES FOR TUMOR CELLS IRRADIATED IN VIVO * , 1961, Annals of the New York Academy of Sciences.

[11]  P. Vaupel,et al.  Nicotinamide exerts different acute effects on microcirculatory function and tissue oxygenation in rat tumors. , 1993, International journal of radiation oncology, biology, physics.

[12]  S. Hill,et al.  Temporal heterogeneity in microregional erythrocyte flux in experimental solid tumours. , 1995, British Journal of Cancer.

[13]  M. Horsman,et al.  Radiosensitization by nicotinamide in vivo: a greater enhancement of tumor damage compared to that of normal tissues. , 1987, Radiation research.

[14]  D. Chaplin,et al.  Intermittent blood flow in a murine tumor: radiobiological effects. , 1987, Cancer research.

[15]  M. Horsman,et al.  Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time. , 1993, British Journal of Cancer.

[16]  J. Overgaard,et al.  The potentiation of radiation damage by nicotinamide in the SCCVII tumour in vivo. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.